Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. NJ BioHistory (TM)
Career
Job Search Post a Job Destination NJ
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: Athena Partners - Eliminating women's cancers
Facilities
 
Events
 

ORCA Monthly Meeting: March 16 - Requirements & Best Practices for Management Review

Conference on Biosimilars, University of Washington, Seattle - March 19-20. Sign up today!



BioHistory Moment: Iditarod Trail used to transport diphtheria serum to Nome.

Balto

In 1925, a life-or-death race to save the children of Nome from a diphtheria epidemic made an international hero of one sled dog, and led to the creation of Alaska's Iditarod sled dog race. A diphtheria epidemic threatened remotely located Nome, and air transportation was unavailable to transport serum from Anchorage nearly a thousand miles away.

The solution: A relay of dog teams transported serum on the Iditarod Trail from Nenana to Nome, and every village enroute provided its best team and driver for the next leg continually moving the serum toward Nome. Gunnar Kaasen, a Norwegian musher, drove the final two legs into Nome behind his lead dog Balto through a blizzard with 80 mph winds to deliver 300,000 units of diphtheria antitoxin to Dr. Curtis Welch, the only doctor in Nome.

The serum arrived in time, prevented the epidemic and saved hundreds of lives. The 20 mushers had covered nearly 700 miles in slightly more than 127 hours in temperatures of minus40° Fahrenheit below zero and strong winds. The serum run received worldwide press coverage and the mushers received special gold medals and other recognition. In 1926, a statue of Balto, the heroic lead dog, was erected in New York's Central Park.

More...

Learn about Seattle's Life Science Incubator Facility

PNDRI Building, First Hill, Seattle, WA. Seattle's Life Science Incubator Research facility was commissioned in 1988, and is a contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical space and management offices. The faciility is centrally located in close proximity to downtown Seattle, the University of Washington, the Fred Hutchinson Cancer Research Center, and more.

Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in New Jersey, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • Emergent BioSolutions Chairman and CEO Fuad El-Hibri recognized  Emergent BioSolutions announced that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland's outstanding international business leaders.
    Emergent Biosolutions Inc.  March 11, 2010  


  • Hanger patient Staff Sgt. Heath Calhoun competing in 2010 Paralympic Winter Games  As Hanger patient Staff Sgt. Heath Calhoun gets set to compete in the 2010 Paralympic Winter Games as an alpine skier, his story will be featured on NBC Nightly News.
    Hanger Orthopedic Group  March 11, 2010  


  • Pfizer discontinues a Phase 3 study of figitumumab  Pfizer announced the discontinuation of A4021018 (also known as ADVIGO 1018), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced NSCLC.
    Pfizer Inc.  March 11, 2010  


  • Two Phase 3 trials of sunitinib did not meet the primary endpoint  Pfizer announced that two Phase 3 studies of Sutent(R) (sunitinib malate) in advanced breast cancer did not meet their primary endpoints.
    Pfizer Inc.  March 11, 2010  


  • NPS Pharmaceuticals reports 2009 results and 2010 outlook  NPS reported a net loss of $2.0 million or $0.04 per diluted share for the fourth quarter of 2009, compared to a net loss of $8.5 million or $0.18 per diluted share for the fourth quarter of 2008.
    NPS Pharmaceuticals, Inc.  March 11, 2010  


More... | Submit News Release | Advertising...

News

New Job Postings...

Free Job Posting Trial Offer
  • Scientist/Senior Scientist, Formulations Seattle Genetics, Inc. (WA)
  • Quality Assurance Validation Associate Seattle Genetics, Inc. (WA)
  • Quality Assurance Manufacturing Associate Seattle Genetics, Inc. (WA)
  • Clinical Research Nurse Supervisor Puget Sound Blood Center (WA)
  • CMC Associate Project Manager Seattle Genetics, Inc. (WA)
More... | Job Advertising... | About Job Postings...
Recruiter's Studio

New Facilities Available...

ATC clean room constructors...validation guaranteed!

  • 890 Embarcadero Road Property -- West Sacramento, CA
  • CompleGen Lab/Office Space -- Seattle, WA
  • Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
ATC Construction

Upcoming Events...

  • 03/11/2010: Yale BioHaven Entrepreneurship Series: Jonathan Rothberg
  • 03/11/2010: Online Webinar: Performing Investigations for Environment
  • 03/11/2010: Online Webinar: Environmental Excursion Investigations
  • 03/15/2010: Pharmacovigilance
  • 03/16/2010: Pharma & Biotech Supply Chain Asia 2010
More... | Submit Event | Event Advertising...
Master's Degree in Biomedical Regulatory Affairs

Learn About New Jersey's BioHistory

Learn About New Jersey's BioHistory Why is there a life science industry in New Jersey? Is the industry growing? What do other states have?

Through New Jersey BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in New Jersey.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


March - National Colorectal Cancer Awareness Month

National Colorectal Cancer Awareness Month

As a leading health organization for 25 years, the Prevent Cancer Foundation, the vision of Carolyn Aldigé, has catapulted cancer prevention to prominence and provided more than $113 million in support of cancer prevention and early detection research, education and community outreach programs across the country.

More...


BioFact

(1984) - Allan Wilson and Russell Higuchi of the University of CA at Berkeley become the first to clone genes from an extinct species. They clone genes from the preserved skin of a quagga, a form of zebra that has been extinct for a hundred years.


It's a Small World

  Pollen Grain Pollen Grain  

Science Quote

"Science is facts; just as houses are made of stones, so is science made of facts; but a pile of stones is not a house and a collection of facts is not necessarily science."

-  Henri Poincare
 (1854-1912)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

NewJerseyLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of New Jersey.